The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.
You must log in or register to comment.
For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)
deleted by creator
It delays dementia by 4-7 months, and also causes bleeding and swelling in the brain which killed 3 out of 1,700 participants in the study.
It’s better than nothing I guess but it’s not a particularly good treatment.
The results regarding amyloid plaques just keep going back and forth over time, I’m very curious how this will ultimately play out. I suppose even if the plaques are a symptom rather than the underlying cause it can still be helpful clearing them away.
